|
|
Mylan N V 's Yearly EPS from Cont. Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
MYL Annual EPS from Cont. Operations Growth |
2019
|
2018
|
2017
|
2016
|
2015
|
Y / Y Annual EPS from Cont. Operations Change |
-95.65 % |
-46.92 % |
38.3 % |
-47.78 % |
-27.71 % |
Annual EPS from Cont. Operations (in $) |
$0.03 |
$0.69 |
$1.30 |
$0.94 |
$1.80 |
Annual EPS from Cont. Operations Growth
Comment |
Mylan N V experienced detoriation of Annual EPS from Cont. Operations for the fiscal year ended 2019 by -95.65% to $ 0.03 , compare to $ 0.69 in Annual EPS from Cont. Operations reported in the previous year. The decline in company's annual EPS from Cont. Operations accelerated, from the -46.92 % decrease, in the fiscal year ended 2018.
Mylan N V Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2019 Annual EPS from Cont. Operations within Healthcare Sector | Y/Y EPS from Cont. Operations Growth % | 2019 Annual EPS from Cont. Operations | Generex Biotechnology Corp | | | |